<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0208851.ref044">
 <label>44</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Pal</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Dowd</surname>
   <given-names>KA</given-names>
  </name>, 
  <name>
   <surname>Brien</surname>
   <given-names>JD</given-names>
  </name>, 
  <name>
   <surname>Edeling</surname>
   <given-names>MA</given-names>
  </name>, 
  <name>
   <surname>Gorlatov</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Johnson</surname>
   <given-names>S</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus</article-title>. 
  <source>PLoS pathogens</source>. 
  <year>2013</year>;
  <volume>9</volume>(
  <issue>4</issue>):
  <fpage>e1003312</fpage>
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1003312" xmlns:xlink="http://www.w3.org/1999/xlink">10.1371/journal.ppat.1003312</ext-link> ; PubMed Central PMCID: PMC3630103.
  <?supplied-pmid 23637602?>
  <pub-id pub-id-type="pmid">23637602</pub-id>
 </mixed-citation>
</ref>
